Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL ALFADEX for Systemic scleroderma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where ALPROSTADIL ALFADEX was used for Systemic scleroderma.

Most Reported Side Effects for ALPROSTADIL ALFADEX

Side Effect Reports % Deaths Hosp.
Stevens-johnson syndrome 9 20.0% 7 3
Sepsis 7 15.6% 5 6
Toxic epidermal necrolysis 7 15.6% 7 2
Peripheral arterial occlusive disease 6 13.3% 1 6
Right ventricular failure 6 13.3% 5 6
Anal polyp 5 11.1% 0 5
Blood pressure abnormal 5 11.1% 0 5
Cardiac dysfunction 5 11.1% 5 5
Dermatitis allergic 5 11.1% 0 5
Disease progression 5 11.1% 5 5
Duodenitis 5 11.1% 0 5
Galectin-3 increased 5 11.1% 5 5
Gastritis 5 11.1% 0 5
Left ventricular dysfunction 5 11.1% 5 5
Multiple organ dysfunction syndrome 5 11.1% 5 5

Other Indications for ALPROSTADIL ALFADEX

Product used for unknown indication (17) Poor peripheral circulation (6)

Other Drugs Used for Systemic scleroderma

RITUXIMAB (554) MYCOPHENOLATE MOFETIL (474) TOCILIZUMAB (332) METHOTREXATE (307) NINTEDANIB (204) PREDNISOLONE (156) CYCLOPHOSPHAMIDE (142) PREDNISONE (128) BOSENTAN (120) IMATINIB (118)

Related Pages

ALPROSTADIL ALFADEX Full Profile All Systemic scleroderma Drugs ALPROSTADIL ALFADEX Demographics ALPROSTADIL ALFADEX Timeline